BRPI0417493A - terapia com toxina botulìnica para distúrbios da pele - Google Patents
terapia com toxina botulìnica para distúrbios da peleInfo
- Publication number
- BRPI0417493A BRPI0417493A BRPI0417493-3A BRPI0417493A BRPI0417493A BR PI0417493 A BRPI0417493 A BR PI0417493A BR PI0417493 A BRPI0417493 A BR PI0417493A BR PI0417493 A BRPI0417493 A BR PI0417493A
- Authority
- BR
- Brazil
- Prior art keywords
- skin disorders
- botulically
- toxin therapy
- toxin
- therapy
- Prior art date
Links
- 208000017520 skin disease Diseases 0.000 title abstract 3
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 239000003053 toxin Substances 0.000 title 1
- 231100000765 toxin Toxicity 0.000 title 1
- 108030001720 Bontoxilysin Proteins 0.000 abstract 2
- 229940053031 botulinum toxin Drugs 0.000 abstract 2
- 206010006585 Bunion Diseases 0.000 abstract 1
- 208000003643 Callosities Diseases 0.000 abstract 1
- 206010020649 Hyperkeratosis Diseases 0.000 abstract 1
- 208000000260 Warts Diseases 0.000 abstract 1
- 231100001102 clostridial toxin Toxicity 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 201000010153 skin papilloma Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A61K38/4893—Botulinum neurotoxin (3.4.24.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/731,973 US8048423B2 (en) | 2003-12-09 | 2003-12-09 | Botulinum toxin therapy for skin disorders |
PCT/US2004/041327 WO2005056050A1 (en) | 2003-12-09 | 2004-12-08 | Botulinum toxin therapy for skin disorders |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0417493A true BRPI0417493A (pt) | 2007-05-29 |
BRPI0417493B1 BRPI0417493B1 (pt) | 2018-11-13 |
BRPI0417493B8 BRPI0417493B8 (pt) | 2021-05-25 |
Family
ID=34634457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0417493A BRPI0417493B8 (pt) | 2003-12-09 | 2004-12-08 | uso de uma toxina botulínica para tratamento de distúrbios da pele |
Country Status (10)
Country | Link |
---|---|
US (1) | US8048423B2 (pt) |
EP (2) | EP1691830B1 (pt) |
JP (1) | JP4937758B2 (pt) |
AT (2) | ATE446769T1 (pt) |
AU (1) | AU2004296870B2 (pt) |
BR (1) | BRPI0417493B8 (pt) |
CA (1) | CA2549550C (pt) |
DE (2) | DE602004023886D1 (pt) |
ES (2) | ES2289591T3 (pt) |
WO (1) | WO2005056050A1 (pt) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8871224B2 (en) * | 2003-12-09 | 2014-10-28 | Allergan, Inc. | Botulinum toxin therapy for skin disorders |
US20080008777A1 (en) * | 2004-02-12 | 2008-01-10 | Philip Radovic | Methods of treating a bunion |
US7276244B2 (en) * | 2004-02-12 | 2007-10-02 | Philip Radovic | Methods of treating abnormalities of the first metatarsophalangeal joint of the foot |
US8497081B2 (en) | 2004-02-24 | 2013-07-30 | Allergan, Inc. | Botulinum toxin screening assays |
ATE533853T1 (de) * | 2004-02-24 | 2011-12-15 | Allergan Inc | Botulinumtoxin-screening-assays |
US20050191321A1 (en) | 2004-02-26 | 2005-09-01 | Allergan, Inc. | Methods for treating headache |
US20100266638A1 (en) | 2004-02-26 | 2010-10-21 | Allergan, Inc. | Headache treatment method |
US9211248B2 (en) | 2004-03-03 | 2015-12-15 | Revance Therapeutics, Inc. | Compositions and methods for topical application and transdermal delivery of botulinum toxins |
US20050220821A1 (en) * | 2004-03-31 | 2005-10-06 | Allergan, Inc. | Pressure sore treatment |
US20050220734A1 (en) * | 2004-04-02 | 2005-10-06 | Allergan, Inc. | Therapy for melanin related afflictions |
US7922983B2 (en) * | 2005-07-28 | 2011-04-12 | Kimberly-Clark Worldwide, Inc. | Sterilization wrap with additional strength sheet |
US20060024331A1 (en) * | 2004-08-02 | 2006-02-02 | Ester Fernandez-Salas | Toxin compounds with enhanced membrane translocation characteristics |
US8343929B2 (en) * | 2004-09-23 | 2013-01-01 | Toxcure, Inc. | Treating neoplasms with neurotoxin |
EP2298339B1 (en) * | 2004-09-23 | 2015-07-15 | Toxcure, Inc. | Treating neoplasms with neurotoxin |
US20060067950A1 (en) * | 2004-09-27 | 2006-03-30 | Merz Pharma Gmbh & Co. Kgaa | Clostridial neurotoxins for use in wound healing |
US7655244B2 (en) | 2005-02-01 | 2010-02-02 | Allergan, Inc. | Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions |
US7749515B2 (en) | 2005-02-01 | 2010-07-06 | Allergan, Inc. | Targeted delivery of botulinum toxin to the sphenopalatine ganglion |
US7419675B2 (en) * | 2005-05-26 | 2008-09-02 | Allergan, Inc. | Method for treating peritoneal adhesions |
US20070128226A1 (en) * | 2005-12-01 | 2007-06-07 | Philip Radovic | Methods of treating pain associated with abnormalities of the first metatarsophalangeal joint of the foot |
US7824694B2 (en) * | 2006-01-12 | 2010-11-02 | Allergan, Inc. | Methods for enhancing therapeutic effects of a neurotoxin |
CN101074935B (zh) * | 2006-05-19 | 2011-03-23 | 清华大学 | 探测器阵列及设备 |
US8870876B2 (en) | 2009-02-13 | 2014-10-28 | Tarsus Medical Inc. | Methods and devices for treating hallux valgus |
US8277459B2 (en) | 2009-09-25 | 2012-10-02 | Tarsus Medical Inc. | Methods and devices for treating a structural bone and joint deformity |
US8652141B2 (en) | 2010-01-21 | 2014-02-18 | Tarsus Medical Inc. | Methods and devices for treating hallux valgus |
US8696719B2 (en) | 2010-06-03 | 2014-04-15 | Tarsus Medical Inc. | Methods and devices for treating hallux valgus |
JP6444032B2 (ja) * | 2011-01-07 | 2018-12-26 | ルバンス セラピュティックス インク.Revance Therapeutics,Inc. | 治療用又は美容用毒素組成物の局所塗布、除去及び不活化のための方法及びキット |
ES2424294B1 (es) | 2012-03-22 | 2014-07-21 | Lipotec, S.A. | Exopolisacárido para el tratamiento y/o cuidado de la piel, mucosas, cabello y/o uñas |
EP2649983A1 (en) | 2012-04-13 | 2013-10-16 | Lipotec, S.A. | Compounds which inhibit neuronal exocytosis (II) |
JP6470678B2 (ja) | 2012-04-13 | 2019-02-13 | ルブリゾル アドバンスド マテリアルズ, インコーポレイテッド | ニューロンの開口分泌を阻害する化合物(ii) |
EP2649985A1 (en) | 2012-04-13 | 2013-10-16 | Lipotec, S.A. | Compounds which inhibit neuronal exocytosis (III) |
EP2649984A1 (en) | 2012-04-13 | 2013-10-16 | Lipotec, S.A. | Compounds which inhibit neuronal exocytosis |
US9259343B2 (en) | 2012-07-06 | 2016-02-16 | Newman Technologies LLC | Device for mitigating plantar fasciitis |
CN105451710A (zh) | 2013-03-22 | 2016-03-30 | 利普泰股份公司 | 用于治疗和/或护理皮肤、粘膜和/或指甲的外泌多糖 |
JP2020510100A (ja) | 2017-03-13 | 2020-04-02 | フィリップ アンドリュー ラドヴィッチ | 足の第1中足趾節関節の異常の治療に使用するための神経筋毒素 |
JP7096845B2 (ja) * | 2017-05-31 | 2022-07-06 | アラーガン、インコーポレイテッド | メラノサイトの活動亢進および/または過剰メラニンに関連する障害の治療のためのボツリヌス神経毒素 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5562907A (en) * | 1993-05-14 | 1996-10-08 | Arnon; Stephen S. | Method to prevent side-effects and insensitivity to the therapeutic uses of toxins |
US5437291A (en) | 1993-08-26 | 1995-08-01 | Univ Johns Hopkins | Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction |
US6974578B1 (en) | 1993-12-28 | 2005-12-13 | Allergan, Inc. | Method for treating secretions and glands using botulinum toxin |
US5766605A (en) | 1994-04-15 | 1998-06-16 | Mount Sinai School Of Medicine Of The City University Of New York | Treatment of autonomic nerve dysfunction with botulinum toxin |
ATE215832T1 (de) | 1994-05-09 | 2002-04-15 | William J Binder | Botulinumtoxin zur reduktion von migraine - kopfschmerzen |
US5670484A (en) * | 1994-05-09 | 1997-09-23 | Binder; William J. | Method for treatment of skin lesions associated with cutaneous cell-proliferative disorders |
GB9508204D0 (en) | 1995-04-21 | 1995-06-07 | Speywood Lab Ltd | A novel agent able to modify peripheral afferent function |
DE69620888T2 (de) * | 1996-11-27 | 2002-08-14 | William J Binder | Neurotoxine zur Behandlung von Hauterkrankungen bei Säugetieren |
US6063768A (en) * | 1997-09-04 | 2000-05-16 | First; Eric R. | Application of botulinum toxin to the management of neurogenic inflammatory disorders |
ATE314859T1 (de) * | 1998-10-27 | 2006-02-15 | Mayo Foundation | Botulinumtoxine zur verstärkung der wundheilung |
US6477410B1 (en) * | 2000-05-31 | 2002-11-05 | Biophoretic Therapeutic Systems, Llc | Electrokinetic delivery of medicaments |
US6265379B1 (en) | 1999-10-13 | 2001-07-24 | Allergan Sales, Inc. | Method for treating otic disorders |
US6139845A (en) | 1999-12-07 | 2000-10-31 | Allergan Sales, Inc. | Method for treating cancer with a neurotoxin |
US7838007B2 (en) * | 1999-12-07 | 2010-11-23 | Allergan, Inc. | Methods for treating mammary gland disorders |
US6464986B1 (en) | 2000-04-14 | 2002-10-15 | Allegan Sales, Inc. | Method for treating pain by peripheral administration of a neurotoxin |
US6299893B1 (en) | 2000-04-17 | 2001-10-09 | Marvin Schwartz | Method to reduce hair loss and stimulate hair regrowth |
US6306423B1 (en) | 2000-06-02 | 2001-10-23 | Allergan Sales, Inc. | Neurotoxin implant |
US6423319B1 (en) | 2000-10-04 | 2002-07-23 | Allergan Sales, Inc. | Methods for treating muscle injuries |
CA2451923C (en) | 2001-07-27 | 2009-10-20 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Botulinum toxin in the treatment or prevention of acne |
DE10146647A1 (de) * | 2001-09-21 | 2003-04-24 | Marc Heckmann | Arzneimittel zur Prophylaxe und Therapie von Bromhidrosis |
EP1534376B1 (en) * | 2002-06-25 | 2016-08-31 | Theraject, Inc. | Rapidly dissolving micro-perforator for drug delivery and other applications |
US6945952B2 (en) * | 2002-06-25 | 2005-09-20 | Theraject, Inc. | Solid solution perforator for drug delivery and other applications |
US6776991B2 (en) * | 2002-06-26 | 2004-08-17 | Allergan, Inc. | Methods for treating priapism |
US20040009180A1 (en) * | 2002-07-11 | 2004-01-15 | Allergan, Inc. | Transdermal botulinum toxin compositions |
US20060153876A1 (en) * | 2003-02-24 | 2006-07-13 | Ira Sanders | Cell membrane translocation of regulated snare inhibitors, compositions therefor, and methods for treatment of disease |
AU2004216901B2 (en) * | 2003-03-06 | 2009-11-12 | Botulinum Toxin Research Associates, Inc. | Treatment of chronic chalazion and hordeolum with botulinum toxin |
-
2003
- 2003-12-09 US US10/731,973 patent/US8048423B2/en not_active Expired - Fee Related
-
2004
- 2004-12-08 EP EP04813630A patent/EP1691830B1/en not_active Not-in-force
- 2004-12-08 BR BRPI0417493A patent/BRPI0417493B8/pt not_active IP Right Cessation
- 2004-12-08 DE DE602004023886T patent/DE602004023886D1/de active Active
- 2004-12-08 ES ES04813630T patent/ES2289591T3/es active Active
- 2004-12-08 AU AU2004296870A patent/AU2004296870B2/en not_active Ceased
- 2004-12-08 WO PCT/US2004/041327 patent/WO2005056050A1/en active IP Right Grant
- 2004-12-08 DE DE602004008329T patent/DE602004008329T2/de active Active
- 2004-12-08 EP EP07010256A patent/EP1820510B1/en not_active Not-in-force
- 2004-12-08 JP JP2006543997A patent/JP4937758B2/ja not_active Expired - Fee Related
- 2004-12-08 AT AT07010256T patent/ATE446769T1/de not_active IP Right Cessation
- 2004-12-08 AT AT04813630T patent/ATE369874T1/de not_active IP Right Cessation
- 2004-12-08 CA CA2549550A patent/CA2549550C/en not_active Expired - Fee Related
- 2004-12-08 ES ES07010256T patent/ES2335310T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
ATE369874T1 (de) | 2007-09-15 |
ES2289591T3 (es) | 2008-02-01 |
WO2005056050A1 (en) | 2005-06-23 |
JP2007513964A (ja) | 2007-05-31 |
BRPI0417493B8 (pt) | 2021-05-25 |
AU2004296870B2 (en) | 2010-05-20 |
DE602004008329D1 (de) | 2007-09-27 |
DE602004008329T2 (de) | 2008-05-08 |
DE602004023886D1 (de) | 2009-12-10 |
CA2549550A1 (en) | 2005-06-23 |
EP1691830B1 (en) | 2007-08-15 |
ATE446769T1 (de) | 2009-11-15 |
EP1820510A1 (en) | 2007-08-22 |
EP1691830A1 (en) | 2006-08-23 |
JP4937758B2 (ja) | 2012-05-23 |
AU2004296870A1 (en) | 2005-06-23 |
US20050123567A1 (en) | 2005-06-09 |
CA2549550C (en) | 2012-07-17 |
US8048423B2 (en) | 2011-11-01 |
ES2335310T3 (es) | 2010-03-24 |
BRPI0417493B1 (pt) | 2018-11-13 |
EP1820510B1 (en) | 2009-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0417493A (pt) | terapia com toxina botulìnica para distúrbios da pele | |
BR0111698A (pt) | Método para o tratamento de um distúrbio de movimento | |
BR0309888A (pt) | Tratamento intracraniano de distúrbios neuropsiquiátricos por neurotoxinas clostridiais tal como a toxina da botulina | |
BR0110030A (pt) | Método para tratamento de dor através da administração periférica de uma neurotoxina | |
BR0318269A (pt) | composições, alvos, métodos e dispositivos para a terapia de distúrbios oculares e perioculares | |
DK2282766T3 (da) | Suturlinie-indgivelsesteknik med anvendelse af botulinumtoksiner | |
MXPA03002576A (es) | Metodos para tratar lesiones musculares. | |
BRPI0410041A (pt) | métodos para tratamento de dor de cabeça de sinusite | |
BR0014710A (pt) | Métodos para o tratamento de dor | |
BRPI0502346A (pt) | processo de tratamento cosmético para prevenir e/ou tratar as peles sensìveis e/ou secas, utilização de uma quantidade eficaz de pelo menos um microorganismo notadamente probiótico e/ou uma de suas frações e/ou um de seus metabólitos e composição cosméticas e/ou dermatológica | |
BRPI0612119A2 (pt) | tratamento de distúrbio auto-imunes com uma neuroxotina | |
BR112014009851A2 (pt) | moduladores de receptor de nmda e usos dos mesmos | |
BR0310099A (pt) | método para tratar dislipidemia ou uma doença associada com a dislipidemia | |
MX2013013809A (es) | Dispositivos expandibles con revestimiento de una composicion de paclitaxel. | |
WO2003092617A3 (en) | Combinations for the treatment of inflammatory skin disorders | |
MX2010006731A (es) | Uso de un componente neurotoxico de un complejo de toxina de clostridium botulinum para reducir o prevenir efectos secundarios. | |
SG10201805552PA (en) | Sodium channel modulators for the treatment of pain and diabetes | |
MX2021010058A (es) | Formulaciones de rapamicina tópicas y su uso en el tratamiento de angiofibromas faciales y otros trastornos de la piel. | |
WO2019166412A9 (en) | Modulation of pla2-g1b in therapy | |
MX2022010186A (es) | Neurotoxinas botulinas para uso en terapia. | |
ATE525084T1 (de) | Verwendung von mindestens einem botulinum- neurotoxin zur behandlung von schmerzen infolge therapeutischer behandlungen für das aids-virus | |
WO2004110380A3 (en) | Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents | |
BR112014001170A2 (pt) | cateter, especialmente um cateter permanente, para tratamento de problemas funcionais e/ou doenças da bexiga e/ou próstata | |
PH12019502721A1 (en) | Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin | |
ATE505194T1 (de) | Neue therapeutische verwendungen von inecalcitol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09T | Decision of refusal: decision cancelled [chapter 9.2.1 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 9.2 NA RPI NO 2463 DE 20/03/2018 POR TER SIDO INDEVIDA. |
|
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 13/11/2018, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/12/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 18A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2700 DE 04-10-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |